Musaffa Logo

Our certifications

Independent proof that every stock and portfolio meets halal standards.

How we screen every stock
METHODOLOGY

How we screen every stock

Our 5-step halal methodology, in 90 seconds.

Eurobio Scientific SA ALERS.PA

€22.20 €0.10 (0.45%) 1D

Last Updated: Jun 23, 12:00 AM·XPAR

ALERS.PA Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: February 04, 2026

Report Source: 2025 2nd Quarter Report

Analyst's Ratings for Eurobio Scientific SA (ALERS.PA)

Based on 9 analysts giving stock ratings to Eurobio Scientific SA in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
33
Buy
56
Hold
11
Sell
0
Strong Sell
0
Eurobio Scientific SA

Eurobio Scientific SA. Stock Analysis ALERS.PA

France Health Care Micro Cap Report:
Eurobio-Scientific SA provides in vitro diagnostics solutions. The company is engaged in activities ranging from discovery to the commercialization of specialty diagnostic products. The firm owns a portfolio of diagnostic products in three specialty areas: infectious diseases; Alzheimer's disease, and cancer. The company consists of Tetanos Quick Stick (TQS), which is an unitary test enabling to determine the tetanus vaccination status. The company has a portfolio of in-house and co-developed products, including AclarusDx (a blood-based test for the detection of biomarkers specific for Alzheimer's disease). The portfolio includes BJI Inoplex for prosthetic infections and EHT Dx14 for breast cancer (both in validation phase). The co-developed products include research programs for the identification of predictive biomarkers of response for anti-HER2 and anti-angiogenic therapies, among others. The company operates through Genbio and Eurobio Capforce Plus.
Read More

Eurobio Scientific SA (ALERS.PA) Chart

Key Statistics of Eurobio Scientific SA (ALERS.PA)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

€22.20€22.30

Today's Open

€22.30

Volume

104.00

P/E Ratio (TTM)

45.67

52 Week Range

€20.40€25.95

Market Cap

226.12M

Avg. Volume

1858.33

Dividend Yield

-

Financial Metrics & Statements of Eurobio Scientific SA (ALERS.PA)

FAQ's for Eurobio Scientific SA (ALERS.PA)

  • According to Musaffa’s Shariah screening methodology, Eurobio Scientific SA (ALERS.PA) is currently classified as HALAL as of February 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
  • A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Eurobio Scientific SA using these criteria to determine its compliance status.
  • Muslim investors may consider investing in Eurobio Scientific SA if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
  • Musaffa determines the Shariah status of Eurobio Scientific SA by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
  • The Shariah compliance status of Eurobio Scientific SA may be updated periodically when new financial statements, earnings reports, or business activity information become available.
  • Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
  • You can check the latest Shariah compliance status of Eurobio Scientific SA on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.